Introduction
Sun Pharma is a leading player in the pharmaceutical industry, recognized for its robust product portfolio and consistent financial performance. This article delves into Sun Pharma Share Price Target 2024, 2025, 2027, 2030 and 2040, offering insights based on expert analysis and financial data.
What Is Sun Pharmaceutical Industries Limited?
Sun Pharma, founded in 1983, is an Indian multinational pharmaceutical company headquartered in Mumbai. It manufactures and distributes pharmaceutical formulations and active pharmaceutical ingredients to over 100 countries.
Overview Of Sun Pharma Company
Sun Pharma is one of India’s largest pharmaceutical companies, specializing in a wide range of therapeutic areas, including neurology, cardiology, nephrology, urology, gynecology, respiratory, oncology, ophthalmology, dental, and nutrition. The company operates 43 manufacturing units across India and ranks as the 4th largest supplier of generic drugs globally.
Key Data:
| Market Cap | ₹3,72,546.61 Crore |
| Book Value | ₹98.75 |
| Face Value | ₹1 |
| 52 Week High: | ₹1,640.23 |
| 52 Week Low | ₹977.50 |
| P/B Ratio | 14.95 |
| Dividend Yield | 0.93% |
Financial Data Analysis Of Sun Pharma Company
Sun Pharma’s financial health is evident from its key ratios and financial performance metrics.
Key Ratios:
| PE Ratio | 380.23 |
| Return On Assets (ROA) | 11.02% |
| Current Ratio | 1.96 |
| Return On Equity (ROE) | 7.00% |
History Of Sun Pharma Share Price Target From 2024 to 2040
Sun Pharma has shown a bullish trend in the share market. Over the past years, the company’s shares have demonstrated significant growth, making it an attractive investment for long-term investors.
Sun Pharma Share Price Target
2024 Share Price Targets:
Sun Pharma is expected to continue its growth trajectory with a focus on expanding its product portfolio and entering new markets.
| Year | 1st Price Target | 2nd Price Target |
| 2024 | ₹1440 | ₹1680 |
2025 Share Price Targets:
With strong consumer healthcare products and a significant presence in emerging markets, Sun Pharma is poised for further growth.
| Year | 1st Price Target | 2nd Price Target |
| 2025 | ₹1710 | ₹1880 |
2027 Share Price Targets:
Sun Pharma’s continued investment in R&D and innovative product development will drive its share price higher.
| Year | 1st Price Target | 2nd Price Target |
| 2027 | ₹2110 | ₹2280 |
2030 Share Price Targets:
Sun Pharma’s established presence in the US market and its robust generic drug segment will support long-term growth.
| Year | 1st Price Target | 2nd Price Target |
| 2030 | ₹2810 | ₹3050 |
2040 Share Price Targets:
Looking further ahead, Sun Pharma’s ability to navigate market challenges and capitalize on opportunities will determine its future success.
| Year | 1st Price Target | 2nd Price Target |
| 2040 | ₹4500 | ₹5500 |
How To Purchase Sun Pharma Shares
You can purchase Sun Pharma shares through the following trading platforms:
- Zerodha
- Upstox
- Groww
- Angelone
Peer Companies
Sun Pharma competes with several notable pharmaceutical companies:
- Cipla
- Divis Labs
- Lupin
- Mankind Pharma
- Zydus Life
Investor Types and Holding Ratios
Sun Pharma’s growth is supported by a diverse investor base:
| Investor Type | Holding Ratio |
| Promoters Holding | 53.90% |
| Public Holding | 9.80% |
| Foreign Institutional Investors (FII) | 18.00% |
| Domestic Institutional Investors (DII) | 18.30% |
Advantages and Disadvantages Of Sun Pharma Share
Advantages
- Significant profit growth in the last year.
- Consistent revenue growth over the past three years.
- Efficient cash conversion cycle and good cash flow management.
- Increasing book value per share.
Disadvantages
- Poor ROE ratio over the last three years.
- High EBITDA and PE ratio, which can negatively impact growth.
Also Read: Adani Ports Share Price Target 2024, 2025, 2027, 2030, 2040
FAQ
What is the main activity of Sun Pharma Company?
Manufacturing and distributing pharmaceutical formulations and active pharmaceutical ingredients.
Who is the owner of Sun Pharma Company?
Sun Pharma was founded by Dilip Shanghvi.
Should I invest in Sun Pharma Share company right now?
Investment decisions should be based on thorough research and consultation with financial experts.
What is the future growth of Sun Pharma Company?
Sun Pharma is expected to continue its growth, driven by its strong product portfolio and expansion into new markets.
Conclusion
Sun Pharma is a dominant player in the pharmaceutical industry with strong financials and a promising growth outlook. Long-term investors can expect substantial returns based on the company’s historical performance and future potential.
Disclaimer: The financial market is inherently risky. This article is for informational purposes only and does not constitute investment advice. Please consult a certified financial advisor before making any investment decisions.
